MK 826
a carbapenem antibiotic, arising from concentration-dependent plasma protein binding in rats and monkeys; structure in first source
Also Known As:
3-((2-(((3-carboxyphenyl)amino)carbonyl)pyrrolidin-4-yl)thio)-4-methyl-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-en-2-carboxylic acid monosodium salt; MK-826
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
Related Drugs and Biologics